Covered recipient · General Payments record
VIOLETA D AVRAMOV
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,617.24
- Reported across 252 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $796.11 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $210.32 | 12 |
| PFIZER INC. | $206.73 | 18 |
| Lilly USA, LLC | $134.12 | 10 |
| Teva Pharmaceuticals USA, Inc. | $44.61 | 3 |
| ARGENX US, INC. | $31.97 | 2 |
| Medtronic, Inc. | $28.60 | 1 |
| Alexion Pharmaceuticals, Inc. | $27.68 | 2 |
| UCB, Inc. | $21.71 | 1 |
| Biogen, Inc. | $21.04 | 1 |
| INSIGHTEC,INC | $18.02 | 1 |
| Neurocrine BioSciences, Inc. | $17.48 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.97 | 1 |
| EISAI INC. | $16.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.72 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254173 | CMS |
| ABBVIE INC. | $23.02 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254175 | CMS |
| ABBVIE INC. | $13.66 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254177 | CMS |
| ABBVIE INC. | $23.60 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254179 | CMS |
| ABBVIE INC. | $28.51 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254181 | CMS |
| ABBVIE INC. | $16.73 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254183 | CMS |
| ABBVIE INC. | $16.12 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254185 | CMS |
| ABBVIE INC. | $18.15 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254187 | CMS |
| ABBVIE INC. | $17.27 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254189 | CMS |
| ABBVIE INC. | $10.99 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254191 | CMS |
| ABBVIE INC. | $7.40 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254193 | CMS |
| ABBVIE INC. | $18.15 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103254195 | CMS |
| Alexion Pharmaceuticals, Inc. | $14.20 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093928945 | CMS |
| Alexion Pharmaceuticals, Inc. | $13.48 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094031725 | CMS |
| ARGENX US, INC. | $16.88 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106275 | CMS |
| ARGENX US, INC. | $15.09 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142109355 | CMS |
| Biogen, Inc. | $21.04 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104837252 | CMS |
| Eisai Inc. | $16.86 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110787649 | CMS |
| InSightec,Inc | $18.02 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110445439 | CMS |
| Lilly USA, LLC | $13.10 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135477504 | CMS |
| Lilly USA, LLC | $11.32 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135440739 | CMS |
| Lilly USA, LLC | $13.13 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135474344 | CMS |
| Lilly USA, LLC | $13.59 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509290 | CMS |
| Lilly USA, LLC | $12.85 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135466518 | CMS |
| Lilly USA, LLC | $17.32 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509286 | CMS |
| Lilly USA, LLC | $9.23 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135466520 | CMS |
| Lilly USA, LLC | $12.96 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135492654 | CMS |
| Lilly USA, LLC | $19.31 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135498796 | CMS |
| Lilly USA, LLC | $11.31 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509288 | CMS |
| Medtronic, Inc. | $28.60 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117100247 | CMS |
| Neurocrine Biosciences, Inc. | $17.48 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150867258 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.97 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118856479 | CMS |
| PFIZER INC. | $8.78 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131557762 | CMS |
| PFIZER INC. | $18.00 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131164254 | CMS |
| PFIZER INC. | $8.71 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131698357 | CMS |
| PFIZER INC. | $4.45 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131698687 | CMS |
| PFIZER INC. | $9.93 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131576136 | CMS |
| PFIZER INC. | $10.12 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131661532 | CMS |
| PFIZER INC. | $10.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131666386 | CMS |
| PFIZER INC. | $16.40 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131525960 | CMS |
| PFIZER INC. | $11.66 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131627522 | CMS |
| PFIZER INC. | $13.81 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131507040 | CMS |
| PFIZER INC. | $9.40 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131628285 | CMS |
| PFIZER INC. | $11.31 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131683726 | CMS |
| PFIZER INC. | $12.25 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131760620 | CMS |
| PFIZER INC. | $13.33 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131776993 | CMS |
| PFIZER INC. | $3.11 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131961586 | CMS |
| PFIZER INC. | $11.60 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132096705 | CMS |
| PFIZER INC. | $24.24 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131135737 | CMS |
| PFIZER INC. | $9.51 | 11/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131097926 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.63 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151454830 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.44 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151454870 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.54 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151454912 | CMS |
| UCB, Inc. | $21.71 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143367780 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.